The impact of GDF-15, a biomarker for metformin, on the risk of coronary artery disease, breast and colorectal cancer, and type 2 diabetes and metabolic traits: a Mendelian randomisation study
Authors: Shiu Lun Au Yeung, Shan Luo, C. Mary Schooling
Published: 2019-06-03
DOI:
10.1007/s00125-019-4913-2
Source:
Full article
Abstract
No abstract found.